v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating Activities:    
Net income (loss) $ 22,294 $ (327,322)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Remeasurement of contingent consideration to fair value 10,655 922
Remeasurement of derivative instruments 9,795 (18,717)
Depreciation 8,300 6,419
Share-based compensation 8,270 7,783
Amortization of debt issuance costs 4,769 5,676
Amortization of intangible assets 4,563 4,215
Amortization of operating lease assets 2,732 4,037
Deferred income tax expense 1,824 2,244
Impairments of investments 1,132 0
Loss on investment revaluation - Ceribell, Inc. 0 2,614
Other 1,174 11
Changes in operating assets and liabilities:    
Accounts receivable, net (14,669) (3,896)
Inventories (1,546) (2,494)
Other current and non-current assets (4,199) 6,437
Accounts payable and accrued current and non-current liabilities (38,771) (30,516)
Taxes payable 1,713 5,934
Litigation provision liability (2,820) 226
SNIA environmental liability 0 360,393
Net cash provided by operating activities 15,216 23,966
Investing Activities:    
Purchases of property, plant, and equipment (14,290) (10,790)
Other (290) 162
Net cash used in investing activities (14,580) (10,628)
Financing Activities:    
Repayment of long-term debt obligations (95,938) (4,375)
Other 1,693 (46)
Net cash used in financing activities (94,245) (4,421)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (2,237) 5,964
Net (decrease) increase in cash, cash equivalents, and restricted cash (95,846) 14,881
Cash, cash equivalents, and restricted cash at beginning of period 635,552 723,556
Cash and cash equivalents at end of period 539,706 738,437
Supplemental noncash investing and financing transactions:    
Capital expenditures included in accounts payable $ 10,461 $ 2,379